Key terms

About SPRO

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SPRO news

Mar 18 6:26am ET Spero Therapeutics’ Robust Drug Pipeline and Positive Trial Advancements Prompt Buy Rating by TipRanks Mar 15 4:40pm ET Spero Therapeutics files $300M mixed securities shelf by TipRanks Mar 13 11:25pm ET TD Cowen Sticks to Its Hold Rating for Spero Therapeutics (SPRO) by TipRanks Mar 13 4:06pm ET Spero Therapeutics reports Q4 EPS (96c), consensus (10c) by TipRanks Mar 05 10:25am ET Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call by TipRanks Mar 05 4:55am ET Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call by TipRanks Mar 01 12:19pm ET Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call by TipRanks Feb 28 8:12am ET Spero Therapeutics announces clearance by U.S. FDA of IND for SPR206 by TipRanks Feb 10 4:31am ET Spero Therapeutics Announces Chief Legal Officer’s Resignation by TipRanks Jan 05 8:19am ET Spero Therapeutics expects cash to fund requirements into late 2025 by TipRanks Jan 05 8:19am ET Spero Therapeutics provides 2024 anticipated milestones by TipRanks Jan 03 7:45am ET Spero Therapeutics’ Promising Outlook: Clinical Milestones and Strategic GSK Partnership by TipRanks Jan 02 8:15am ET Spero announces first patient, first visit for Phase 3 PIVOT-PO trial by TipRanks

No recent press releases are available for SPRO

SPRO Financials

1-year income & revenue

Key terms

SPRO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SPRO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments